Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16905505 | 0.95 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL9877840 | 0.84 | — | — | |
| SCHEMBL439771 | 0.82 | — | — | |
| SCHEMBL2848689 | 0.79 | MAPK1 (0.35) | MAPK1 | |
| SCHEMBL2848692 | 0.79 | MAPK1 (0.35) | MAPK1 | |
| SCHEMBL2832131 | 0.77 | KMT2A (0.33) | — | |
| SCHEMBL852389 | 0.69 | MAPK1 (0.48) | MAPK1 | |
| SCHEMBL2389180 | 0.69 | TSHR (0.36) | — | |
| SCHEMBL3705756 | 0.67 | — | — | |
| SCHEMBL5242956 | 0.67 | CA1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3094638-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2017-11-08 | — | — | EP | disclosed |
| US-20160365520-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2016-12-15 | — | — | US | disclosed |
| EP-3008228-A1 | POLARITY REVERSAL ELECTROLYSIS | Azad, Abdul R. M. (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20160097134-A1 | Conversion of Pharmaceuticals and Chemicals into different Compounds by Polarity Reversal Electrolysis | AZAD ABDUL R M (US) | 2016-04-07 | — | — | US | disclosed |
| WO-2014200916-A1 | POLARITY REVERSAL ELECTROLYSIS | AZAD ABDUL R M (US) | 2014-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160097134-A1 | Conversion of Pharmaceuticals and Chemicals into different Compounds by Polarity Reversal Electrolysis | PEF1, CYP11B2, CYP3A4 | MAPK1 869/4885 |
| US-20160365520-A1 | METAL COMPLEXES | SOD1, AP1M1, AP3M1 | MAPK1 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.